Clinical Trials

The goal of the proposed study is to develop and validate a myoelectrically-controlled power-assist upper extremity exoskeleton (powered exoskeleton) to assist with upper extremity motion in patients with traumatic peripheral nerve injuries who have inadequate motor function.

The purpose of this study is to prospectively evaluate the development of neuropathy symptoms and corresponding changes in physical function in persons receiving oxaliplatin based chemotherapy.

The purpose of this study is to prospectively evaluate the patient-reported outcomes data of T-DM1 induced peripheral neuropathy like prior research focused on paclitaxel-, paclitaxel/CBDCA-, oxaliplatin-, and cisplatin-induced peripheral neuropathy, to better understand the similarities and differences of chemotherapy-induced peripheral neuropathy (CIPN) symptoms caused by different agents, their pathogenesis, and impacts.

The purpose of this study is to bridge the existing gap by assessing the reliability and validity of the Norfolk QOL-DN questionnaire for patients with Diabetic Lumbosacral Radiculoplexus Neuropathy (DLRPN).